PUBLISHER: TechNavio | PRODUCT CODE: 2172677
PUBLISHER: TechNavio | PRODUCT CODE: 2172677
The global tourettes syndrome drugs market is forecasted to grow by USD 739.6 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global tourettes syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in neurobiological research and targeted drug development, rising global awareness and enhanced diagnostic capabilities, favorable regulatory environments and financial incentives for orphan drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.6% |
| CAGR | 6.9% |
| Incremental Value | $739.6 mn |
Technavio's global tourettes syndrome drugs market is segmented as below:
By Product
By Distribution Channel
By Application
Geography
This study identifies the evolution of non-dopaminergic pharmacological interventions as one of the prime reasons driving the global tourettes syndrome drugs market growth during the next few years. Also, integration of digital therapeutics and wearable monitoring technologies and strategic focus on precision medicine and pharmacogenomic tailoring will lead to sizable demand in the market.
The report on the global tourettes syndrome drugs market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global tourettes syndrome drugs market vendors that include AstraZeneca Plc, Bausch Health Co Inc., Biogen Inc., Boehringer Ingelheim GmbH, Bristol Myers Squibb Co., Catalyst Pharmaceuticals Inc., Eli Lilly and Co., H. Lundbeck AS, Ionis Pharmaceuticals Inc., Johnson and Johnson, Kyowa Kirin Co. Ltd., Neurocrine Biosciences Inc., Novartis AG, Otsuka Pharmaceutical Co Ltd., Sun Pharmaceutical Industries, Synendos Therapeutics AG, Tasly Pharmaceutical Group Co., Teva Pharmaceutical Ltd., Viatris Inc.. Also, the global tourettes syndrome drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.